Clinical Trials Logo

Clinical Trial Summary

Comparative retrospective study of two anal canal brachytherapy techniques aimed at boosting [low dose rate (LDR) and high dose rate (HDR)]


Clinical Trial Description

Efficacy of anal canal interstitial brachytherapy evaluated by local relapse rate, Tolerance of interstitial brachytherapy of the anal canal evaluated by the rate of chronic toxicities. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03465501
Study type Observational
Source Institut Paoli-Calmettes
Contact
Status Completed
Phase N/A
Start date August 17, 2007
Completion date July 28, 2016

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05060471 - PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients Phase 2
Active, not recruiting NCT00754078 - A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy Phase 2
Not yet recruiting NCT03731754 - "Cross" Closure for Reconstructing the Perineal Wound of Abdominoperineal Resection N/A
Recruiting NCT05374252 - Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients Phase 3
Recruiting NCT02185443 - Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases Phase 2
Recruiting NCT05040815 - Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer Phase 2
Recruiting NCT03403465 - Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers Phase 2
Active, not recruiting NCT03946358 - Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL) Phase 2
Withdrawn NCT03942900 - Immunomonitoring and Biomarker Research in Patients With Squamous Cell Anal Carcinoma